天美传媒

ISSN: 2476-2067

Toxicology: 天美传媒 Access
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentry   
  • Toxicol 天美传媒 Access 2022 8: 175, Vol 8(2)
  • DOI: 10.4172/2476-2067.1000175

Toxicology of Anti-Diabetics Drug

James K White*
Department of Pharmacy, Harrison College of Pharmacy, Auburn University, United States
*Corresponding Author: James K White, Department of Pharmacy, Harrison College of Pharmacy, Auburn University, United States, Email: jkwhite@auburn.edu

Received: 14-Feb-2022 / Manuscript No. tyoa-22-58283 / Editor assigned: 16-Feb-2022 / PreQC No. tyoa-22-58283 / Reviewed: 02-Mar-2022 / QC No. tyoa-22-58283 / Revised: 08-Mar-2022 / Manuscript No. tyoa-22-58283 / Published Date: 15-Mar-2022 DOI: 10.4172/2476-2067.1000175

Abstract

Diabetes mellitus is the century's epidemic and diabetes continues to increase at an early phase without appropriate diagnostic techniques. Data shows that about 1 in 4 persons with this illness are unaware. Type 2 diabetes is defined as relative insulin deficiency caused by β-cells (present in the pancreas) dysfunction. It is a chronic complex disorder that requires patient self-management for control of abnormal glucose levels and continuous medical care, and multifactorial risk reduction strategies to normalize blood glucose levels, lipid profiles, and blood pressure to avert or diminish short and long term issues.

Introduction

Diabetes mellitus (DM) is a group of metabolic diseases characterized by chronic hyperglycemia resulting from

Defects in insulin secretion, insulin action, or both. Its prevalence has been increasing steadily all over the world. There’s no cure for diabetes. When you have type 2 diabetes, your pancreas usually creates some insulin. But either it’s not enough or your body doesn’t use it like it should. Insulin resistance, when your cells don’t respond to insulin, usually happens in fat, liver, and muscle cells [1-3]. Treatment for type 2 diabetes involves keeping a healthy weight, eating right, and exercising. Some people need medication, too. People living with type 2 DM are more vulnerable to various forms of both short- and long-term complications, which often lead to their premature death. Metformin drug has been shown to prevent diabetes in people who are at high risk and decrease most of the diabetic complications. Recent reports on metformin, not only indicate some implications such as reno protective properties. Have been suggested for metformin, but some reports indicate its adverse effects as well that are negligible when its Benefits are brought into account [4].

Pharmacodynamics of metformin

It works mainly by suppressing excessive hepatic glucose production, through a reduction in gluconeogenesis. Other potential effects of metformin include an increase in glucose uptake, an increase in insulin signaling, a decrease in fatty acid and triglyceride synthesis, and an increase in fatty acid β-oxidation.

Adverse effect

Diabetes mellitus is rising to an alarming epidemic level. Early diagnosis of diabetes and prediabetes is essential. Screening for diabetes especially in underdeveloped countries is essential to reduce late diagnosis. Metformin has not significant adverse effects; however, it may cause a serious condition called lactic acidosis.

Metformin usually does not cause hypoglycemia; however, low blood sugar may occur if this drug is used with other

Anti-diabetic drugs. Gastrointestinal intolerance is one of the most frequently occurred and lactic acidosis is a rare, but causes serious adverse effects. Metformin is a first-line therapy for type 2 Diabetes mellitus and is one of the most commonly prescribed drugs.

References

  1. Soleimani V, Delghandi PS, Moallem SA, Karimi G (2019. Phytother Res 1627-1638.
  2.               , ,

  3. Douros A, Lix LM, Fralick M, Dell'Aniello S, Shah BR, Ronksley PE, et al.(2020) Ann Intern Med 417-425.
  4.               , ,

  5. Egbuna C, Awuchi CG, Kushwaha G, Rudrapal M, Patrick-Iwuanyanwu KC, et al. (2021) . Curr Top Med Chem 1067-1095.
  6.               , ,

  7. Essmat N, Soliman E, Mahmoud MF, Mahmoud AAA (2020) Diabetes Metab Syndr 1179-1186.
  8.                 , ,

Citation: White JK (2022) Toxicology of Anti-Diabetics Drug. Toxicol 天美传媒 Access 8: 175. DOI: 10.4172/2476-2067.1000175

Copyright: © 2022 White JK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top